Skip to main content
stars and dogs

A humorous look at the companies that caught our eye, for better or worse, this week

Innergex Renewable Energy (STAR)

The answer, my friend, is blowin’ in the wind. So is the money, apparently. Shares of Innergex Renewable Energy surged after the company purchased the class B shares of Mountain Air – which owns six wind farms in Idaho – for US$56.8-million. The acquisition – the second funded by a private placement of Innergex shares with Hydro-Québec that was announced in February – “should provide Innergex with additional cash immediately available for distribution,” the company said. The stock’s got the wind at its back.

INE - TSX

Cogeco Communications (STAR)

Benefits of the work-from-home trend: 1) Short commutes; 2) No need to shower, shave or perform other basic grooming; 3) A financial boost for investors who own telecommunications stocks. Shares of Cogeco Communications jumped after the company – which offers broadband internet, TV and phone services in Canada and the United States – announced better-than-expected earnings and strong broadband subscriber growth as more people work from home during the pandemic – or play Grand Theft Auto. Strictly on coffee breaks, of course.

CCA - TSX

Sleep Number (DOG)

Putting money under your mattress may be safe. But putting money into a mattress stock can be risky. Hammered by store closings and weak consumer demand during the coronavirus pandemic, Sleep Number – which makes adjustable and “smart” beds – said sales plunged 20 per cent in the second quarter as it swung to a loss of US$12.6-million. With the stock sinking on the results and still well below its precoronavirus high, the only number investors are concerned about is the amount of money they are losing.

SNBR - Nasdaq

Moderna (STAR)

Bad news: Coronavirus infections are soaring in the United States, where reluctance to embrace common-sense safety measures such as physical distancing and wearing masks is contributing to the rampant spread of the disease. Good news: U.S. drug maker Moderna announced encouraging results from a Phase 1 trial of its experimental COVID-19 vaccine, which induced a “robust” immune response in all 45 test participants. Too bad there isn’t a vaccine for stupidity.

MRNA - Nasdaq

Norwegian Cruise Line Holdings (DOG)

Going on a cruise is probably the last thing on most people’s minds – right after investing in a cruise operator. Shares of Norwegian Cruise Line Holdings took on more water after the company – which has suspended most voyages through at least the end of September – announced an offering of US$250-million of shares and US$925-million of notes as it seeks to stay afloat during the pandemic. Judging by the stock’s performance, some investors are already jumping for the lifeboats.

NCLH - NYSE

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an editorial error

Report a technical issue

Editorial code of conduct

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 15/11/24 4:00pm EST.

SymbolName% changeLast
INE-T
Innergex Renewable Energy Inc
-1.27%8.55
CCA-T
Cogeco Communications Inc
-0.6%69.36
SNBR-Q
Sleep Number Corp
-9.6%12.34
MRNA-Q
Moderna Inc
-7.34%36.85
NCLH-N
Norwegian Cruise Ord
-0.97%26.42

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe